Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04380571
Other study ID # Fecal incontinence
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 4, 2018
Est. completion date February 28, 2019

Study information

Verified date May 2020
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Fecal incontinence is one of the most psychological frustrating problems. It occurs in children due to many causes. There is a wide range of non-invasive therapeutic approaches like Kegel exercise, Biofeedback, and posterior tibial nerve stimulation. However, up till now, there are no established guidelines for treatment.

the objective of this study is to evaluate and compare the early effect of Biofeedback therapy versus bilateral transcutaneous posterior tibial nerve stimulation (TPNS) as non-invasive methods in the treatment of functional non-retentive fecal incontinence (FNRFI) in children.


Description:

Functional non-retentive fecal incontinence (FNRFI) requires prolonged treatment with a wide range of non-invasive therapeutic approaches like Kegel exercise, Biofeedback, and posterior tibial nerve stimulation (PTNS). However, up till now, there are no established guidelines for treatment.1 The aim of this study is to evaluate and compare the early effect of Biofeedback therapy versus bilateral transcutaneous posterior tibial nerve stimulation (TPTNS) as non-invasive methods in the treatment of (FNRFI) in children.

Methodology: The current prospective randomized controlled study included 93 children with FNRFI who were randomly divided and allocated into three groups. Group A treated by conventional methods through dietetic regulation and Kegal exercises. Group B treated by biofeedback therapy while group C received bilateral (TPTNS). Initial manometric findings including resting pressure, squeeze pressure, 1st sensation, 1st urge, and intense urge were recorded and repeated after 3 and 6 months together with incontinence score recorded in using St' Mark's (Varizey) with the primary endpoint of improvement of the incontinence score more than 50%.


Recruitment information / eligibility

Status Completed
Enrollment 93
Est. completion date February 28, 2019
Est. primary completion date December 27, 2018
Accepts healthy volunteers No
Gender All
Age group 5 Years to 15 Years
Eligibility Inclusion Criteria:

- FecaI incontinence

- Normal defecation frequency,

- Normal bowel habits and

- Normal stool consistency

Exclusion Criteria:

- Children who are not cooperative,

- Children with traumatic sphincter injury,

- Children with fecal impaction,

- Children with spinal diseases causing incontinence,

- Children with anorectal malformation,

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Biofeedback
Biofeedback therapy in addition to the conventional measures done in the control Group. It was performed in the same position used for baseline manometry. The used protocol included strength and sensory training, twice weekly for 3 months. Strength training was performed by a double-lumen rectal PVC balloon clothed catheter (MMS U-72210).
Electrical stimulation
A positive auto adhesive electrode was applied above the medial malleolus over the S3 dermatome. A second negative electrode was applied just below the same malleolus. Both electrodes were linked to an electrical stimulation device ( EMS physio Ltd, OX129 F, England) with a low frequency current (10 Hz), and adjustable intensity.
Other:
Traditional treatment
Conventional treatment through Kegal exercises and dietetic regulation where they had received bulky food including vegetables, fruits bran and cereals. Fast foods, spicy drinks and caffeine should be limited in child's diet. Local hygiene and zinc oxide application to the perianal skin were advised to prevent skin excoriation.

Locations

Country Name City State
Egypt Banha University Banha Banha

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incontinence score using St' Mark's (Vaiszey) Questionnaire ranging from zero (indicating complete continence) to 24 (indicating total incontinence). 3 months after intervention
Primary incontinence score using St' Mark's (Vaiszey) Questionnaire ranging from zero (indicating complete continence) to 24 (indicating total incontinence). 6 months after intervention
Secondary Resting pressure (mm hg) Pressure during relaxation of the anal sphincter 3 months after intervention
Secondary Resting pressure (mm hg) Pressure during relaxation of the anal sphincter 6 months after intervention
Secondary Squeeze pressure (mm hg) Pressure during contraction of the anal sphincter 3 months after intervention
Secondary Squeeze pressure (mm hg) Pressure during contraction of the anal sphincter 6 months after intervention
Secondary First sensation (volume of the balloon by cm water) First sensation of the stool in the rectum 3 months after intervention
Secondary First sensation (volume of the balloon by cm water) First sensation of the stool in the rectum 6 months after intervention
Secondary First Urge(volume of the balloon by cm water) The patient is trying to hold defecation and he can 3 months after intervention
Secondary First Urge(volume of the balloon by cm water) The patient is trying to hold defecation and he can 6 months after intervention
Secondary Intense urge (volume of the balloon by cm water) The Patent can no longer control the defecation 3 months after intervention
Secondary Intense urge (volume of the balloon by cm water) the Patent can no longer control the defecation 6 months after intervention
See also
  Status Clinical Trial Phase
Recruiting NCT03825575 - Sacral Neuromodulation as Treatment for Fecal Incontinence N/A
Completed NCT00605826 - A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence N/A
Withdrawn NCT02208258 - Efficacy, Safety, and Performance Study of a Novel Device Designed to Manage Fecal Incontinence in Hospitalized Bedridden Patients With Liquid to Semi-formed Stool. N/A
Completed NCT01957969 - French Post-Inscription Study on Sacral Neuromodulation in the Treatment of Fecal Incontinence N/A
Completed NCT01939821 - A Pilot Study to Evaluate Educational Programs to Improve Fecal Incontinence Care in Nursing Homes N/A
Completed NCT01710579 - Normal Values in Ano-rectal 3D High Resolution Manometry N/A
Recruiting NCT00530933 - Tibial Nerve Stimulation for Faecal Incontinence N/A
Withdrawn NCT00522691 - Efficacy of Sacral Nerve Stimulation Before Definitive Implantation N/A
Completed NCT00565136 - Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms Phase 1/Phase 2
Completed NCT00677508 - Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
Completed NCT05032534 - Examination of a New Irrigation System for Transanal Irrigation in Children With Fecal Incontinence N/A
Completed NCT05058326 - Severity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women
Completed NCT03746834 - NASHA/Dx as a Perianal Implant for the Treatment of Persistent Fecal Incontience After Anorectal Malformation Phase 4
Completed NCT00124904 - Biofeedback for Fecal Incontinence N/A
Completed NCT03028636 - LIBERATE - PRO: Eclipseâ„¢ System Registry
Completed NCT04097288 - Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects Phase 1
Completed NCT05621629 - Management of FI After Surgery of ARM
Withdrawn NCT04138602 - BTL Emsella Chair Versus Sham for the Treatment of Fecal Incontinence N/A
Completed NCT03252951 - Physical Therapy for Anal Incontinence N/A
Completed NCT04478799 - Transcutaneous Posterior Nerve Stimulation inTreatment of Fecal Incontience N/A